Lightning strikes four times for Palmer
Andre Palmer was awarded a fourth four-year R01 from the National Institutes of Health. The new R01, which totals $2.8M, focuses on enginering PEGylated earthworm hemoglobin as a safe and efficacious red blood cell substitute for use in transfusion medicine.CBE Professor and Chairman
Palmer's team includes co-PIs from the University of California San Diego and The Ohio State University Wexner Medical Center.
The latest R01 - the fourth received in under a year - brings Palmer's NIH R01 total to $8.4M.
Palmer is also expecting a Department of Defense grant which recently received approval.